A Bill Regular Session, 2015 SENATE BILL 688

Similar documents
A Bill Regular Session, 2011 SENATE BILL 839

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED JULY 11, 2014

A Bill Second Extraordinary Session, 2018 HOUSE BILL 1010

A Bill Regular Session, 2019 SENATE BILL 450

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572


A Bill Regular Session, 2019 HOUSE BILL 1978

As Engrossed: S3/6/01 S3/22/01

A Bill Regular Session, 2015 SENATE BILL 768

A Bill Regular Session, 2017 HOUSE BILL 1762

A Bill Regular Session, 2017 SENATE BILL 665

AN ACT relating to pharmacy benefit management. Be it enacted by the General Assembly of the Commonwealth of Kentucky:

A Bill Regular Session, 2015 SENATE BILL 6

Authorized By: Richard J. Badolato, Commissioner, Department of Banking and Insurance.

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

A Bill Regular Session, 2019 HOUSE BILL 1260

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*

A Bill Regular Session, 2015 SENATE BILL 844

A Bill Regular Session, 2017 SENATE BILL 138

A Bill Regular Session, 2019 HOUSE BILL 1002

A Bill Regular Session, 2019 SENATE BILL 257

A Bill Regular Session, 2019 SENATE BILL 142

A Bill Regular Session, 2017 HOUSE BILL 1772

A Bill Regular Session, 2017 HOUSE BILL 1460

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 2123

A Bill Regular Session, 2017 SENATE BILL 236

A Bill First Extraordinary Session, 2017 SENATE BILL 3

A Bill Regular Session, 2009 SENATE BILL 231

A Bill Regular Session, 2019 HOUSE BILL 1002

A Bill Regular Session, 2019 HOUSE BILL 1320

Hall of the House of Representatives 91st General Assembly - Regular Session, 2017 Amendment Form

A Bill Regular Session, 2009 SENATE BILL 830

A Bill Regular Session, 2011 SENATE BILL 292

A Bill Second Extraordinary Session, 2016 HOUSE BILL 1001

A Bill Regular Session, 2011 SENATE BILL 593

A Bill Regular Session, 2009 SENATE BILL 38

A Bill Regular Session, 2005 SENATE BILL 1091

Contact your County Treasurer for more information.

STATE OF NEW YORK IN ASSEMBLY

A Bill Regular Session, 2009 SENATE BILL 128

A Bill Regular Session, 2019 SENATE BILL 571

A Bill Regular Session, 2019 SENATE BILL 576

A Bill Regular Session, 2005 SENATE BILL 543

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.

A Bill Regular Session, 2017 SENATE BILL 37

A Bill Regular Session, 2019 SENATE BILL 211

A Bill Regular Session, 2013 HOUSE BILL 1143

AN ACT. relating to the use of maximum allowable cost lists related to BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

A Bill Regular Session, 2009 HOUSE BILL 2203

A Bill Regular Session, 2013 HOUSE BILL 1229

SENATE BILL No February 10, 2016

A Bill Regular Session, 2013 SENATE BILL 640

A Bill Regular Session, 2013 HOUSE BILL 1143

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill Sponsored by Representative NOSSE; Representative SANCHEZ (Presession filed.

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

A Bill Regular Session, 2017 HOUSE BILL 1953

A Bill Regular Session, 2017 HOUSE BILL 1753

As Engrossed: H2/10/03. For An Act To Be Entitled

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY EICHELBERGER, ARGALL, RAFFERTY, VULAKOVICH AND BROWNE, MAY 18, 2018 AN ACT

A Bill Regular Session, 2017 SENATE BILL 688

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY WHITE, STREET, BARTOLOTTA, COSTA, FONTANA AND BREWSTER, APRIL 18, 2017 AN ACT

Texas Vendor Drug Program Pharmacy Provider Procedure Manual

House Bill 2387 Ordered by the House April 27 Including House Amendments dated April 27

A Bill Regular Session, 2019 SENATE BILL 336

A Bill Regular Session, 2017 SENATE BILL 362

S 2467 S T A T E O F R H O D E I S L A N D

A Bill Regular Session, 2005 SENATE BILL 417

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill Corrected Sponsor

A Bill Regular Session, 2015 SENATE BILL 800

NATIONAL COUNCIL OF INSURANCE LEGISLATORS (NCOIL) Workers Compensation Pharmaceutical Reimbursement Rates Model Act

NATIONAL COUNCILCONFERENCE OF INSURANCE LEGISLATORS (NCOIL) Model Act on Workers Compensation Repackaged Pharmaceutical Reimbursement Rates Model Act

Senate Amendment to Senate Bill No. 539 (BDR ) Title: Yes Preamble: No Joint Sponsorship: No Digest: Yes

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0

Public Employees Benefits Program Legislative Session Bill Tracking Updated: 3/27/2017

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

A Bill Regular Session, 2017 SENATE BILL 422

A Bill Regular Session, 2009 HOUSE BILL 1430

A Bill Regular Session, 2011 HOUSE BILL 1315

A Bill Regular Session, 2017 HOUSE BILL 1726

Referred to Committee on Commerce, Labor and Energy. SUMMARY Revises provisions relating to policies of health insurance.

Chapter 17: Pharmacy and Drug Formulary

Prescription Drug Coverage

DMHC Update CAHP Conference 2017

Second Regular Session Seventy-first General Assembly STATE OF COLORADO INTRODUCED HOUSE SPONSORSHIP SENATE SPONSORSHIP

A Bill Regular Session, 2013 SENATE BILL 797

A Bill Regular Session, 2017 HOUSE BILL 1179

1 SB By Senator Marsh. 4 RFD: Banking and Insurance. 5 First Read: 19-MAY-15. Page 0

2017 Session (79th) A AB183 R Senate Amendment to Assembly Bill No. 183 First Reprint (BDR )

2018 Kentucky Senate Bill No. 5, Kentucky 2018 Regular Session KENTUCKY BILL TEXT

A Bill Regular Session, 2011 HOUSE BILL 1040

Pharmacy Benefit Manager Licensure and Solvency Protection Act

Senate Substitute for HOUSE BILL No. 2026

AN ACT relating to pharmacy benefits in the Medicaid program, and declaring an. Be it enacted by the General Assembly of the Commonwealth of Kentucky:

Use Amgen Assist for help with:

H. R IN THE HOUSE OF REPRESENTATIVES

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016

Nevada s Oral Anticancer Treatment Access Law: What What Clinicians Need to Know

As Introduced. Regular Session H. B. No

A Bill Regular Session, 2005 HOUSE BILL 2823

For An Act To Be Entitled

Transcription:

Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// A Bill Regular Session, SENATE BILL By: Senators Caldwell, Maloch, G. Stubblefield By: Representatives M. Gray, Vaught, Eubanks, Bragg For An Act To Be Entitled AN ACT TO AMEND THE LAWS REGARDING MAXIMUM ALLOWABLE COST LISTS; TO CREATE ACCOUNTABILITY IN THE ESTABLISHMENT OF PRESCRIPTION DRUG PRICING; AND FOR OTHER PURPOSES. Subtitle TO AMEND THE LAWS REGARDING MAXIMUM ALLOWABLE COST LISTS; AND TO CREATE ACCOUNTABILITY IN THE ESTABLISHMENT OF PRESCRIPTION DRUG PRICING. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS: SECTION. Arkansas Code --0 is amended to read as follows: --0. Maximum Allowable Cost Lists. (a) As used in this section: () Maximum Allowable Cost List means a listing of drugs used by a pharmacy benefits manager setting the maximum allowable cost on which reimbursement to a pharmacy or pharmacist may be based; () "Pharmaceutical wholesaler" means a person or entity that sells and distributes prescription pharmaceutical products, including without limitation a full line of brand-name, generic, and over-the-counter pharmaceuticals, and that offers regular and private delivery to a pharmacy; ()() Pharmacist means a licensed pharmacist as defined in --0; ()() Pharmacist services means products, goods, or services *JMB* 0-- :: JMB

As Engrossed: S// SB 0 provided as a part of the practice of pharmacy in Arkansas; ()() Pharmacy means the same as in --0; ()() "Pharmacy acquisition cost" means the amount that a pharmaceutical wholesaler charges for a pharmaceutical product as listed on the pharmacy's billing invoice; () Pharmacy benefits manager means an entity that administers or manages a pharmacy benefits plan or program; and () "Pharmacy benefits manager affiliate" means a pharmacy or pharmacist that directly or indirectly, through one () or more intermediaries owns or controls, is owned or controlled by, or is under common ownership or control with a pharmacy benefits manager; and ()() Pharmacy benefits plan or program means a plan or program that pays for, reimburses, covers the cost of, or otherwise provides for pharmacist services to individuals who reside in or are employed in this state. (b) Before a pharmacy benefits manager places or continues a particular drug on a Maximum Allowable Cost List, the drug: () Shall be listed as therapeutically equivalent and pharmaceutically equivalent A or "B" rated in the United States Food and Drug Administration s most recent version of the Orange Book or Green Book or has an NR or NA rating by Medi-span TM, Gold Standard, or a similar rating by a nationally recognized reference; () Shall be available for purchase by each pharmacy in the state from national or regional wholesalers operating in Arkansas ; Arkansas; and () Shall not be obsolete. (c) A pharmacy benefits manager shall: () Provide access to its Maximum Allowable Cost List to each pharmacy subject to the Maximum Allowable Cost List; () Update its Maximum Allowable Cost List on a timely basis, but in no event longer than seven () calendar days from an increase of ten percent (0%) or more in the pharmacy acquisition cost from sixty percent (0%) or more of the pharmaceutical wholesaler doing business in the state or a change in the methodology on which the Maximum Allowable Cost List is based or in the value of a variable involved in the methodology; () Provide a process for each pharmacy subject to the Maximum 0-- :: JMB

As Engrossed: S// SB 0 Allowable Cost List to receive prompt notification of an update to the Maximum Allowable Cost List; and ()(A)(i) Within three () business days after the applicable fill date, provide Provide a reasonable administrative appeal procedure to allow pharmacies to challenge maximum allowable costs and reimbursements made under a maximum allowable cost for a specific drug or drugs as: (i)(a) Not meeting the requirements of this section; or (ii)(b) Being below the cost at which the pharmacy may obtain the drug pharmacy acquisition cost. (ii) The reasonable administrative appeal procedure shall include the following: (a) A dedicated telephone number and email address or website for the purpose of submitting administrative appeals; (b) The ability to submit an administrative appeal directly to the pharmacy benefits manager regarding the pharmacy benefits plan or program or through a pharmacy service administrative organization; and (c) No less than seven () business days to file an administrative appeal. (B) The pharmacy benefits manager shall respond to the challenge under subdivision (c)()(a)(i) of this section within seven () business days after receipt of the challenge. (C) If a challenge is under subdivision (c)()(a)(i) of this section, the pharmacy benefits manager shall within seven () business days after receipt of the challenge either: (i) If the appeal is upheld: (a) Make the change in the maximum allowable cost; (b) Permit the challenging pharmacy or pharmacist to reverse and rebill the claim in question; and (c) Provide the National Drug Code number that the increase or change is based on to the pharmacy or pharmacist; and (c)(d) Make the change under subdivision (c)()(c)(i)(a) of this section effective for each similarly situated pharmacy as defined by the payor subject to the Maximum Allowable Cost List; 0-- :: JMB

As Engrossed: S// SB 0 or (ii) If the appeal is denied, provide the challenging pharmacy or pharmacist the National Drug Code number from and the name of the national or regional pharmaceutical wholesalers operating in Arkansas that have the drug currently in stock at a price below the Maximum Allowable Cost List.; or (iii) If the National Drug Code number provided by the pharmacy benefits manager is not available below the pharmacy acquisition cost from the pharmaceutical wholesaler from whom the pharmacy or pharmacist purchases the majority of prescription drugs for resale, then the pharmacy benefits manager shall adjust the Maximum Allowable Cost List above the challenging pharmacy's pharmacy acquisition cost and permit the pharmacy to reverse and rebill each claim affected by the inability to procure the drug at a cost that is equal to or less than the previously challenged maximum allowable cost. (d)() A pharmacy benefits manager shall not reimburse a pharmacy or pharmacist in the state an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services. () The amount shall be calculated on a per unit basis based on the same generic product identifier or generic code number. (e) A pharmacy or pharmacist may decline to provide the pharmacist services to a patient or pharmacy benefits manager if, as a result of a Maximum Allowable Cost List, a pharmacy or pharmacist is to be paid less than the pharmacy acquisition cost of the pharmacy providing pharmacist services. (f)() This section does not apply to a Maximum Allowable Cost List maintained by the Arkansas Medicaid Program or the Employee Benefits Division of the Department of Finance and Administration. () This section shall apply to the pharmacy benefits manager employed by the Arkansas Medicaid Program or the Employee Benefits Division if, at any time, the Arkansas Medicaid Program or the Employee Benefits Division engages the services of a pharmacy benefits manager to maintain a Maximum Allowable Cost List. (e)(g) A violation of this section is a deceptive and unconscionable trade practice under --0 et seq. 0-- :: JMB

As Engrossed: S// SB 0 /s/caldwell 0-- :: JMB